Literature DB >> 12842353

A reported case involving impaired driving following self-administration of xylazine.

Matthew E Stillwell1.   

Abstract

A case of suspected drug-impaired driving involving self-administration of xylazine (Xyla-Ject), a veterinary tranquilizing agent, and paroxetine is presented. Qualitative and quantitative analysis of xylazine and paroxetine were performed by gas chromatography with a flame-ionization detector (GC-FID) and gas chromatography/mass spectrometry (GC/MS). Whole blood xylazine and paroxetine concentrations were 0.57 and 0.02 microg/ml, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842353     DOI: 10.1016/s0379-0738(03)00083-5

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  4 in total

1.  The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico.

Authors:  J C Reyes; J L Negrón; H M Colón; A M Padilla; M Y Millán; T D Matos; R R Robles
Journal:  J Urban Health       Date:  2012-06       Impact factor: 3.671

2.  Nanocoral-like Polyaniline-Modified Graphene-Based Electrochemical Paper-Based Analytical Device for a Portable Electrochemical Sensor for Xylazine Detection.

Authors:  Kasrin Saisahas; Asamee Soleh; Kiattisak Promsuwan; Jenjira Saichanapan; Apichai Phonchai; Nabeesathul Sumayya Mohamed Sadiq; Way Koon Teoh; Kah Haw Chang; Ahmad Fahmi Lim Abdullah; Warakorn Limbut
Journal:  ACS Omega       Date:  2022-04-12

3.  Comparison of cardiorespiratory and anesthetic effects of ketamine-midazolam-xylazine-sufentanil and tiletamine-zolazepam-xylazine in miniature pigs.

Authors:  Zhiheng Zhang; Hui Bai; Bo Zhang; Meilun Shen; Li Gao
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

4.  Xylazine Activates Adenosine Monophosphate-Activated Protein Kinase Pathway in the Central Nervous System of Rats.

Authors:  Xing-Xing Shi; Bai-Shuang Yin; Peng Yang; Hao Chen; Xin Li; Li-Xue Su; Hong-Gang Fan; Hong-Bin Wang
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.